HPV疫苗今年内纳入国家免疫规划，在校适龄女生有望免费

Core Viewpoint - The article discusses the significant expansion of the national immunization program in China, with the inclusion of the HPV vaccine aimed at protecting women's health, particularly targeting school-aged girls [3][4]. Group 1: HPV Vaccine Inclusion - The HPV vaccine will be added to the national immunization program, focusing on the bivalent vaccine for school-aged girls [3]. - This marks a shift from a child-centric vaccination approach to a "lifecycle vaccination" strategy [3]. - The bivalent vaccine primarily targets HPV types 16 and 18, which account for 70%-80% of cervical cancer cases [3][4]. Group 2: Cervical Cancer Statistics - Cervical cancer is the second most common malignancy among women globally, with China accounting for 23% of cases and 16% of deaths worldwide [4]. - Nearly all cervical cancer cases (99.7%) are linked to HPV infection, which can lead to cervical cancer if persistent [4]. Group 3: Government Initiatives - The Chinese government has been promoting free HPV vaccination for eligible girls, with 18 provinces and several cities already implementing this initiative [5][6]. - Approximately 60% of eligible girls in China are now covered by the free vaccination policy [5]. Group 4: Vaccine Accessibility and Cost - The production and research capabilities for HPV vaccines in China have significantly improved since 2021, with two domestic bivalent vaccines approved for use [7]. - The price of the HPV vaccine has dropped dramatically, with the lowest bid now at 27.5 yuan per dose, less than one-tenth of the initial price [7]. Group 5: Comprehensive Prevention Strategy - The successful inclusion of the HPV vaccine in the national immunization program is expected to enhance the integration of primary and secondary prevention strategies for cervical cancer [8]. - A comprehensive prevention strategy may include vaccination, screening, and early diagnosis and treatment [8]. Group 6: Future Directions - The national health authorities are preparing a five-year plan to narrow the gap between domestic and international immunization programs, considering the addition of new vaccines and optimizing existing vaccination schedules [9]. - The exploration of vaccine exit strategies for those not suitable for universal vaccination is also on the agenda [9].